cris.boxmetadata.label.title
Potential cancer chemopreventive constituents of the seeds of Dipteryx odorata (tonka bean)
cris.boxmetadata.label.dateissued
01 browse.startsWith.months.may 2003
cris.boxmetadata.label.accesslevel
metadata only access
cris.boxmetadata.label.resourcetype
journal article
cris.boxmetadata.label.authors
Jang D.S.
Park E.J.
Hawthorne M.E.
Graham J.G.
Santarsiero B.D.
Mesecar A.D.
Fong H.H.S.
Mehta R.G.
Pezzuto J.M.
Kinghorn A.D.
cris.boxmetadata.label.publisher
American Chemical Society
cris.boxmetadata.label.abstract
A new cassane diterpene, dipteryxic acid (1), and a new isoflavonolignan, 5-methoxyxanthocercin A (2), as well as four known active compounds, isoliquiritigenin (3), 6,4′-dihydroxy-3′-methoxyaurone (4), sulfuretin (5), and (±)-balanophonin (6), and five known inactive compounds, butin, eriodictyol, 7-hydroxychromone, 7,3′-dihydroxy-8,4′-dimethoxyisoflavone, and (-)-lariciresinol, were isolated from an ethyl acetate-soluble extract of the seeds of Dipteryx odorata, using a bioassay based on the induction of quinone reductase (QR) in cultured Hepa 1c1c7 mouse hepatoma cells to monitor chromatographic fractionation. The structures of compounds 1 and 2 were elucidated by spectroscopic data interpretation. Single-crystal X-ray diffraction analysis was used to confirm the relative stereochemistry of compound 1. Selected compounds (3-5) were evaluated in a mouse mammary organ culture assay, with isoliquiritigenin (3) found to exhibit 76% inhibition at a dose of 10 μg/mL.
cris.boxmetadata.label.citationstartpage
583
cris.boxmetadata.label.citationendpage
587
cris.boxmetadata.label.volume
66
cris.boxmetadata.label.issue
5
cris.boxmetadata.label.language
English
cris.boxmetadata.label.ocdeknowledgeArea
Farmacología, Farmacia
cris.boxmetadata.label.doi
cris.boxmetadata.label.scopusidentifier
2-s2.0-0038188723
cris.boxmetadata.label.pubmedidentifier
cris.boxmetadata.label.source
Journal of Natural Products
cris.boxmetadata.label.containerissn
0163-3864
cris.boxmetadata.label.sponsor
National Cancer Institute P01CA048112 NCI
peru-layout.shadow-copies
Directorio de Producción Científica
Scopus